CEL-SCI Corporation Announces Pricing of Public Offering

VIENNA, Va.–(BUSINESS WIRE)–$CVM #Multikine–CEL-SCI Corporation (“CEL-SCI” or the “Company”) (NYSE American: CVM), a clinical stage cancer immunotherapy company, today announced the pricing of a best-efforts public offering of 6,000,000 shares of its common stock at an offering price of $1.20 per share. Total gross proceeds from the offering, before deducting the placement agent’s fees and … [Read more…]

Firefly Health Reports 15%+ Total Cost of Care Savings for ASO Book of Business

Firefly’s clinically-integrated health plan continues to drive financial results for self-insured employers while delivering health outcomes and member satisfaction WATERTOWN, Mass.–(BUSINESS WIRE)–Firefly Health, a clinically-integrated health plan, announced a 15% lower total cost of care (TCOC) in 2025 across its Administrative Services Only (ASO) book of business when compared against a market-typical benchmark. All customers … [Read more…]

Vertex to Participate in Upcoming May Investor Conferences

BOSTON–(BUSINESS WIRE)–Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced management participation in two upcoming investor conferences. Charlie Wagner, Chief Operating and Financial Officer, will participate in a fireside chat at the 2026 RBC Capital Markets Global Healthcare Conference on Tuesday, May 19, 2026, at 2:35 p.m. ET. Dr. Reshma Kewalramani, Chief Executive Officer and President, will … [Read more…]

Healthcare Enterprises Accelerate AI-Led Transformation

ISG report shows enterprise AI becoming a core operational layer, delivering measurable impact at scale STAMFORD, Conn.–(BUSINESS WIRE)–$III #AI–Healthcare organizations are embedding advanced AI capabilities into core operations to increase efficiency, reduce administrative burdens and enhance care delivery, according to a new research report published today by Information Services Group (ISG) (Nasdaq: III), a global … [Read more…]

United Therapeutics Corporation Presents New Data from TETON-1, ADVANCE OUTCOMES, and Additional Research in Pulmonary Hypertension and Pulmonary Fibrosis at ATS 2026

Presentations of results from the positive TETON phase 3 pivotal studies of inhaled treprostinil in idiopathic pulmonary fibrosis (IPF) include efficacy and safety results from TETON-1 and integrated results from TETON-1 and TETON-2 Results from the successful ADVANCE OUTCOMES study of ralinepag in pulmonary arterial hypertension (PAH) will be presented Additional presentations include an interim … [Read more…]

Fujirebio Announces CE Marking of the Fully Automated Lumipulse® G pTau 217 Plasma Assay

GHENT, Belgium & TOKYO–(BUSINESS WIRE)–#IVD–H.U. Group Holdings Inc. and its wholly owned subsidiary Fujirebio today announced that Fujirebio Europe N.V. has obtained a CE certificate of the Lumipulse G pTau 217 Plasma assay under the Regulation (EU) 2017/746 on in vitro diagnostic medical devices (IVDR). This CLEIA (chemiluminescent enzyme immunoassay) test allows for the quantitative … [Read more…]

Japanese Medtech Startup, CoreTissue BioEngineering, Initiates Randomized Controlled Cohort in the Clinical Trial for Anterior Cruciate Ligament (ACL) Reconstruction Treatment

YOKOHAMA, Japan–(BUSINESS WIRE)–CoreTissue BioEngineering Inc. (“CTBE”), a medical device start-up (Headquarters: Yokohama City, Kanagawa Prefecture, CEO: Yoji Jokura, Ph.D.) announces that the safety evaluation in the safety cohort of its clinical trial for anterior cruciate ligament (ACL) reconstruction with the medical device “Tissue Regenerative Ligament” (development code: CT-ACL001) sponsored by the company has been completed, … [Read more…]

Encompass Health Acquires 7 Acres in Haslet for New Inpatient Rehabilitation Hospital

HASLET, Texas–(BUSINESS WIRE)–Davidson Bogel Real Estate (DB2RE) is pleased to announce the sale of approximately 7 acres of land located at the southwest corner of Haslet Parkway and Harmon Road in Haslet, Texas. Collins Meier, Ryan Turner, David Davidson, Jr., and Edward Bogel represented the seller in the transaction. The buyer, Encompass Health, partnered closely … [Read more…]

Cryo-Cell Receives Acceptance of Compliance Plan From NYSE American

OLDSMAR, Fla.–(BUSINESS WIRE)–Cryo-Cell International, Inc. (NYSE American LLC: CCEL) (the “Company”), the world’s first private cord blood bank to separate and store stem cells in 1992, announced that the NYSE American LLC (the “NYSE American”) has accepted the Company’s previously submitted plan to regain compliance with continued listing standards. As previously disclosed on March 12, … [Read more…]

Saban Community Clinic Breaks Ground on Crenshaw Family Health Center, Expanding Access For Over 287,000 Low-Income People in One of Los Angeles’ Most Underserved Communities

New Facility Will Bring Integrated Care to South Los Angeles, Where Families Lack Reliable Access to Primary Care LOS ANGELES–(BUSINESS WIRE)–#Clinic–Saban Community Clinic (SCC) today breaks ground on its new Crenshaw Family Health Center, a major expansion that will bring comprehensive, community-based healthcare to the heart of South Los Angeles, one of the most underserved … [Read more…]